Other Cancer Types
Additional Boswellia oncology evidence across liver, gastric, haematologic, melanoma, and other cancer models
Boswellia's strongest pages are glioblastoma, breast, colorectal, pancreatic, prostate, NSCLC, and ovarian cancer. Beyond those, several additional areas show promising but earlier-stage relevance.
Additional evidence areas
Hepatocellular and gastric cancer — G2/M arrest and Akt-related suppression have been reported
Haematologic malignancies — preliminary apoptosis and NF-κB-related effects
Melanoma and fibrosarcoma — pro-apoptotic and antiproliferative findings in preclinical work
Practical interpretation
These are not the lead clinical pages for Boswellia, but they expand the biological range of the compound and may become more important as the literature grows.
References
Acetyl-11-keto-beta-boswellic acid inhibits cell proliferation in hepatocellular carcinoma and gastric cancer cells
https://www.sciencedirect.com/science/article/abs/pii/S0041008X24001042
The anti-proliferative effects of a frankincense extract in a window of opportunity Phase Ia clinical trial for patients with breast cancer
https://pmc.ncbi.nlm.nih.gov/articles/PMC10959833/
Jump to another Boswellia page
Core pages
Mechanism deep dives
Practical pages
Cancer-type pages
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.